News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
892,433 Results
Type
Article (89393)
Company Profile (566)
Press Release (802444)
Multimedia
Podcasts (269)
Webinars (42)
Section
Business (267332)
Career Advice (4173)
Deals (40107)
Drug Delivery (216)
Drug Development (91999)
Employer Resources (211)
FDA (18696)
Job Trends (17536)
News (399351)
Policy (40037)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (2)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (2)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (9)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (3)
2027 Biotech Beach Standard (6)
2027 Genetown Elite (5)
2027 Genetown Standard (11)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (8)
Academia (3092)
Academic (2)
Accelerated approval (70)
ADA (51)
Adcomms (44)
Allergies (223)
Alliances (56994)
ALS (272)
Alzheimer's disease (2098)
Antibody-drug conjugate (ADC) (677)
Approvals (19207)
Artificial intelligence (1056)
ASCO (345)
Autoimmune disease (451)
Automation (78)
Bankruptcy (412)
Belgium (13)
Best Places to Work (12636)
BIO (81)
Biologics (20)
BIOSECURE Act (23)
Biosimilars (288)
BioSpace Insights (255)
Biotechnology (341)
Bispecific (5)
Bladder cancer (232)
Brain cancer (98)
Breast cancer (918)
Cancer (7417)
Cardiovascular disease (641)
Career advice (3627)
Career pathing (62)
CAR-T (428)
CDC (78)
CDMO (193)
Celiac Disease (4)
Cell-line development (2)
Cell therapy (1187)
Cervical cancer (62)
Clinical research (80305)
Collaboration (2706)
Commercialization (13)
Company closure (10)
Compensation (1794)
Complete response letters (124)
COVID-19 (3064)
CRISPR (139)
C-suite (1599)
Cystic fibrosis (179)
Data (9901)
Decentralized trials (3)
Denatured (105)
Depression (221)
Dermatology (143)
Diabetes (792)
Diagnostics (7832)
Digital health (80)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (529)
Drug pricing (252)
Drug shortages (39)
Duchenne muscular dystrophy (368)
Earnings (103731)
Editorial (84)
Employer branding (27)
Employer resources (182)
Events (140305)
Executive appointments (1337)
Eye disease (3)
FDA (23489)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (1)
Friedreich's ataxia (26)
Frontotemporal dementia (39)
Funding (2240)
Gene editing (299)
Generative AI (106)
Gene therapy (934)
GLP-1 (1356)
Government (5610)
Grass and pollen (8)
Guidances (436)
Healthcare (21396)
Hematology (198)
HIV (116)
Huntington's disease (79)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (138)
Immunology and inflammation (409)
Immuno-oncology (142)
Indications (258)
Infectious disease (3496)
Inflammatory bowel disease (256)
Inflation Reduction Act (17)
Influenza (160)
Intellectual property (369)
Interviews (827)
IPO (18049)
IRA (61)
Job creations (5211)
Job search strategy (2880)
JPM (73)
Kidney cancer (29)
Kidney disease (99)
Labor market (139)
Layoffs (714)
Leadership (64)
Legal (10177)
Licensing (41)
Liver cancer (116)
Longevity (50)
Lung cancer (1019)
Lymphoma (528)
Machine learning (75)
Management (71)
Manufacturing (1524)
Marketing (14)
MASH (241)
Medical affairs (3)
Medical device (15432)
Medtech (15710)
Mergers & acquisitions (23532)
Metabolic disorders (2026)
mRNA (316)
Multiple sclerosis (231)
Multispecific (1)
NASH (24)
Netherlands (11)
Neurodegenerative disease (589)
Neuropsychiatric disorders (149)
Neuroscience (4129)
Neurotech (2)
NextGen: Class of 2026 (7718)
Non-profit (5164)
Now hiring (96)
Obesity (959)
Opinion (398)
Ovarian cancer (267)
Pain (323)
Pancreatic cancer (412)
Parkinson's disease (466)
Partnered (50)
Patents (773)
Patient advocacy (1)
Patient recruitment (960)
Patient selection (23)
Peanut (75)
People (68800)
Peptides (9)
Pharmaceutical (82)
Pharmacy benefit managers (40)
Phase 1 (24768)
Phase 2 (34836)
Phase 3 (26282)
Pipeline (12667)
Policy (417)
Postmarket research (3561)
Preclinical (11081)
Press Release (72)
Prostate cancer (381)
Psychedelics (95)
Radioligand (1)
Radiopharmaceuticals (423)
Rare diseases (1502)
Real estate (7475)
Recruiting (83)
Regenerative medicine (7)
Regulatory (31472)
Reports (95)
Research institute (2805)
Resumes & cover letters (656)
Rett syndrome (53)
RNA editing (34)
RSV (102)
Schizophrenia (213)
Series A (388)
Series B (273)
Service/supplier (16)
Sickle cell disease (140)
Special edition (36)
Spinal muscular atrophy (199)
Sponsored (59)
Startups (4394)
State (2)
Stem cells (1)
Stomach cancer (22)
Substance use disorders (21)
Supply chain (161)
Tariffs (105)
The Weekly (161)
Vaccines (1395)
Venture capital (166)
Weight loss (643)
Wet AMD (1)
Women's health (172)
Worklife (27)
Date
Today (179)
Last 7 days (634)
Last 30 days (2826)
Last 365 days (33606)
2026 (25058)
2025 (33214)
2024 (37867)
2023 (42564)
2022 (53927)
2021 (58720)
2020 (57662)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1303)
Alabama (115)
Alaska (7)
Arizona (462)
Arkansas (16)
Asia (52887)
Australia (9306)
California (16120)
Canada (4507)
China (1888)
Colorado (695)
Connecticut (723)
Delaware (500)
Europe (122020)
Florida (2461)
Georgia (524)
Hawaii (5)
Idaho (70)
Illinois (1407)
India (137)
Indiana (734)
Iowa (31)
Japan (721)
Kansas (155)
Kentucky (67)
Louisiana (68)
Maine (95)
Maryland (1926)
Massachusetts (11700)
Michigan (457)
Minnesota (888)
Mississippi (7)
Missouri (181)
Montana (37)
Nebraska (31)
Nevada (179)
New Hampshire (92)
New Jersey (4257)
New Mexico (38)
New York (4225)
North Carolina (2112)
North Dakota (12)
Northern California (8146)
Ohio (517)
Oklahoma (31)
Oregon (51)
Pennsylvania (3093)
Puerto Rico (37)
Rhode Island (58)
South America (1672)
South Carolina (98)
South Dakota (2)
Southern California (6399)
Tennessee (268)
Texas (2665)
United States (57356)
Utah (490)
Vermont (2)
Virginia (406)
Washington D.C. (89)
Washington State (1302)
West Virginia (4)
Wisconsin (185)
Wyoming (5)
892,433 Results for "bayer pharma s a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Bayer ends multi-year M&A drought with up to $2.45B Perfuse buy
For $300 million upfront, Bayer is purchasing Perfuse Therapeutics to advance an eye implant for glaucoma and diabetic retinopathy, marking the company’s first pharma acquisition since 2021.
May 6, 2026
·
1 min read
·
Tristan Manalac
Mergers & acquisitions
Lilly’s $25B+ M&A spree captures half of pharma’s 2026 capacity
Over the past decade, Eli Lilly has bought out more biotechs than any of the other top 12 pharmas by revenue—with 10 of those acquisitions arriving just this year.
June 10, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Dr. Jost Reinhard Appointed President of Bayer’s Radiology Business
June 9, 2026
·
3 min read
FDA
FDA’s absent leaders, the millions pharma CEOs make, and pancreatic cancer’s momentum
Fallout from the resignation of FDA Commissioner Marty Makary continues as several other senior regulators are removed from their posts; pharma’s top paid CEOs make up to 358 times more than their employees; Revolution Medicine’s pancreatic cancer results highlight movement in the deadly disease space; more.
May 20, 2026
·
1 min read
·
Jef Akst
C-suite
Lilly, J&J CEOs top pharma’s highest paid list—again
Three pharma CEOs joined the $30 million compensation club in 2025 but Eli Lilly’s David Ricks exceeded his nearest peer by more than $4 million.
May 13, 2026
·
5 min read
·
Annalee Armstrong
Podcast
Lilly’s Foundayo Nod Launches New Battle With Novo, M&A Mania Continues, Tariffs Hit Pharma
The approval of Eli Lilly’s oral obesity drug officially ignites an intense competition with Novo Nordisk’s oral Wegovy; Gilead Sciences and Neurocrine Biosciences keep the M&A train chugging; Trump hits pharma with his long promised tariffs, and the FDA proposes many changes with 2027 budget.
April 8, 2026
·
1 min read
·
Heather McKenzie
Press Releases
Bayer’s AMBELVIST® (gadoquatrane) Receives FDA Approval for Contrast-Enhanced MRI to Detect and Visualize Lesions with Abnormal Vascularity in the Central Nervous System and Non-CNS Body Regions
June 15, 2026
·
10 min read
Press Releases
Bayer Completes Acquisition of Perfuse Therapeutics
June 17, 2026
·
3 min read
Business
Lilly is pharma’s top dog, placing first in innovation and invention: IDEA
Eli Lilly is the first pharma company to take first place in both categories in the eight years that intelligence firm IDEA Pharma has put out its analysis. Skyrocketing sales and multiple FDA approvals helped the company shoot to the top.
May 26, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Bayer Accelerates Pharma Growth on High-Value Portfolio
January 14, 2026
·
13 min read
1 of 89,244
Next